White House regulatory priorities include “aggressive” HHS agenda

HHS cancels fourth USPSTF meeting in a row

A scheduled U.S. Preventive Services Task Force meeting has been canceled, marking the fourth consecutive cancellation by HHS.

July 17, 2026

By Claire Marie Porter

Capitol Hill

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

The Trump administration has a fight on its hands as it pushes forward with a plan to exert greater political control over government funding of science.

AACR urges OMB to retract proposed rule on federally funded research

The American Association for Cancer Research is urging the White House Office of Management and Budget to rescind its recent proposed rule that would give the administration unprecedented political control over government-funded science.

Breaking down Operation Trailblazer: Rolling INDs, outside expert submission help, and one-trial requirement

In this week’s episode of The Cancer Letter Podcast, Paul Goldberg, editor and publisher of The Cancer Letter, and Sara Willa Ernst, reporter, break down HHS’ latest vision for the future: Operation Trailblazer.

July 01, 2026

Regulatory News

To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements

HHS earlier this week rolled out a cluster of initiatives related to simplifying clinical trials, presenting these measures as a government-wide effort to maintain America’s leadership in early-stage drug development.

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

Democratic leaders of the House Committee on Energy and Commerce are urging NIH Director Jay Bhattacharya to voice objections to a proposed rule from the Office of Management and Budget that would give the administration unprecedented political control over government-funded science.

June 26, 2026

Vol.52 No.25

By Jacquelyn Cobb

White House regulatory priorities include “aggressive” HHS agenda

YOU MAY BE INTERESTED IN

HHS cancels fourth USPSTF meeting in a row

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

AACR urges OMB to retract proposed rule on federally funded research

Breaking down Operation Trailblazer: Rolling INDs, outside expert submission help, and one-trial requirement

To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

Renew today!

Subscriber content

Never miss an issue!

Login